Search results with tag "14227"
dx.doi.org/10.14227/DT120205P41 ... - Dissolution Tech
www.dissolutiontech.comDissolution Technologies | MAY 2005 41 Qualification and Validation of USP Apparatus 4 Jon S. Kauffman, Ph.D., Director Pharmaceutical Method Development and Validation Lancaster Laboratories, 2425 New Holland Pike, Lancaster, PA 17605
dx.doi.org/10.14227/DT110104P6 ... - Dissolution Tech
www.dissolutiontech.com6 Dissolution Technologies| FEBRUARY 2004 Comparison of the Effectiveness of Various Deaeration Techniques Owen S. Degenhardt1, Bonnie Waters 1, Anna Rebelo-Cameirao1, Annelene Meyer2, Heiko Brunner2, and Nicholas P.Toltl1,3 email: toltl_nick@lilly.com Introduction The USP General Chapter <711> states, “dissolved gases can cause bubbles to form,which
dx.doi.org/10.14227/DT190412P36 Development and …
www.dissolutiontech.comDissolution Technologies | NOVEMBER 201237 ability is the precision of the method under the same operating conditions over a short time. Reproducibility determines the precision between laboratories.
dx.doi.org/10.14227/DT110204P16 Dissolution …
www.dissolutiontech.com16 Dissolution Technologies| MAY 2004 Dissolution Media Simulating Fasted and Fed States Margareth Marques United States Pharmacopeia Rockville, MD email: mrm@usp.org W hen dissolution testing is used to forecast the in vivo
dx.doi.org/10.14227/DT110304P25 Statistical Properties of ...
www.dissolutiontech.comDissolution Technologies| AUGUST 2004 25 Statistical Properties of the Dissolution Test of USP Carlos D. Saccone1,3, Julio Tessore 1, Silvino A. Olivera2, and Nora S. Meneces1 email: csaccone@fing.edu.uy IntroductionT he dissolution test as defined in the United States Phar-